Literature DB >> 5101350

Halothane hepatitis--a preventable disease?

P Sharpstone, D R Medley, R Williams.   

Abstract

Eleven patients with acute hepatitis following multiple anaesthetics with halothane have been seen at two hospitals during the last four years. Six had massive hepatic necrosis and died. Unexplained fever occurred in nine of the patients; two of these and one other had had previous episodes of jaundice after halothane anaesthesia. Thus, in ten patients the disease could have been avoided.

Entities:  

Mesh:

Year:  1971        PMID: 5101350      PMCID: PMC1795070          DOI: 10.1136/bmj.1.5746.448

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  Anesthetic, circulatory and respiratory effects of fluothane.

Authors:  T K BURNAP; S J GALLA; L D VANDAM
Journal:  Anesthesiology       Date:  1958 May-Jun       Impact factor: 7.892

2.  POSTOPERATIVE death after fluothane.

Authors: 
Journal:  Anesthesiology       Date:  1958 Jul-Aug       Impact factor: 7.892

3.  Antimitochondrial antibodies in jaundice following drug administration.

Authors:  M Rodriguez; F Paronetto; F Schaffner; H Popper
Journal:  JAMA       Date:  1969-04-07       Impact factor: 56.272

4.  Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane.

Authors:  F Paronetto; H Popper
Journal:  N Engl J Med       Date:  1970-08-06       Impact factor: 91.245

5.  Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri.

Authors:  M Hughes; L W Powell
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

6.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

7.  Halothane and liver damage.

Authors:  P H Lorhan
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

8.  Recurrent hepatitis attributable to halothane sensitization in an anesthetist.

Authors:  G Klatskin; D V Kimberg
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

9.  Halothane and liver damage.

Authors:  C R Stephen
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

10.  Hepatitis after exposure to halothane.

Authors:  F M Klion; F Schaffner; H Popper
Journal:  Ann Intern Med       Date:  1969-09       Impact factor: 25.391

View more
  10 in total

1.  In vivo and in vitro studies on irreversible binding of halothane metabolites to proteins.

Authors:  V Hempel; H Remmer
Journal:  Experientia       Date:  1975-06-15

Review 2.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

Review 3.  Halothane hepatitis--fact or fallacy?

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Proc R Soc Med       Date:  1973-01

4.  Halothane hepatitis: fact or fallacy.

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Bull N Y Acad Med       Date:  1973-08

Review 5.  The halothane dilemma: a case for the defence.

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Br Med J       Date:  1971-10-09

Review 6.  Acute liver injury.

Authors:  I C Talbot
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

Review 7.  Halothane anaesthesia and liver damage.

Authors:  J Neuberger; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

8.  Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines.

Authors:  W H Inman; W W Mushin
Journal:  Br Med J       Date:  1974-01-05

9.  Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.

Authors:  H Isaacs; M B Barlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

10.  Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis.

Authors:  C D Price; A R Gibbs; W J Williams
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.